ABG

Ally Bridge Group Portfolio holdings

AUM $101M
1-Year Est. Return 249.88%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+249.88%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$101M
AUM Growth
+$37.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
28
New
Increased
Reduced
Closed

Top Buys

1
+$7.03M
2
+$5.65M
3
+$4.57M
4
ALMS
Alumis Inc
ALMS
+$4.17M
5
URGN icon
UroGen Pharma
URGN
+$4.05M

Top Sells

1
+$7.01M
2
+$4.6M
3
+$4.29M
4
TSHA icon
Taysha Gene Therapies
TSHA
+$2.51M
5
EWTX icon
Edgewise Therapeutics
EWTX
+$980K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRAX icon
1
Praxis Precision Medicines
PRAX
$7.78B
$10.6M 10.5%
32,810
+12,928
NERV icon
2
Minerva Neurosciences
NERV
$218M
$9.97M 9.91%
1,655,500
SLNO
3
DELISTED
Soleno Therapeutics
SLNO
$6.7M 6.65%
200,000
+31,971
OVID icon
4
Ovid Therapeutics
OVID
$446M
$6.26M 6.22%
2,818,459
+1,033,459
CMPS
5
Compass Pathways
CMPS
$1.71B
$5.78M 5.74%
+1,045,000
TARS icon
6
Tarsus Pharmaceuticals
TARS
$2.53B
$5.67M 5.64%
+80,859
SLDB icon
7
Solid Biosciences
SLDB
$674M
$5.52M 5.49%
766,974
+353,349
PMN icon
8
ProMIS Neurosciences
PMN
$86.5M
$5.26M 5.23%
414,219
+164,880
EWTX icon
9
Edgewise Therapeutics
EWTX
$3.9B
$5.07M 5.04%
161,000
-34,000
EPRX
10
Eupraxia Pharmaceuticals
EPRX
$414M
$4.78M 4.75%
660,375
+262,480
CTMX icon
11
CytomX Therapeutics
CTMX
$701M
$4.23M 4.2%
+900,000
IVA
12
Inventiva
IVA
$844M
$4.14M 4.11%
745,300
-754,700
CATX icon
13
Perspective Therapeutics
CATX
$406M
$3.86M 3.84%
+926,557
ABVX
14
Abivax
ABVX
$7.18B
$3.75M 3.73%
33,712
-36,288
ALMS
15
Alumis Inc
ALMS
$2.56B
$3.68M 3.65%
+166,959
URGN icon
16
UroGen Pharma
URGN
$1.3B
$3.63M 3.61%
+202,124
CAPR icon
17
Capricor Therapeutics
CAPR
$1.6B
$3.46M 3.44%
+113,899
WHWK
18
Whitehawk Therapeutics
WHWK
$215M
$2.82M 2.8%
817,939
IKT icon
19
Inhibikase Therapeutics
IKT
$220M
$2.23M 2.21%
+1,325,000
ANTX icon
20
AN2 Therapeutics
ANTX
$151M
$1.8M 1.79%
+526,315
RLMD icon
21
Relmada Therapeutics
RLMD
$664M
$1.47M 1.46%
+210,525
QURE icon
22
uniQure
QURE
$1.88B
– –
0
REPL icon
23
Replimune Group
REPL
$824M
– –
0
TSHA icon
24
Taysha Gene Therapies
TSHA
$1.59B
– –
-457,132
MAZE
25
Maze Therapeutics
MAZE
$1.38B
– –
0
1
2